A suitable streptomycin-resistant mutant for constructing unmarked in-frame gene deletions using rpsL as a counter-selection marker

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Tsai, Yu Kuo ^a   Liou, Ci Hong ^b   Lin, Jung Chung ^b   Ma, Ling ^a   Fung, Chang Phone ^c   Chang, Feng Yee ^b,d   Siu, L Kristopher ^a,b,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Taiwan Centres for Disease Control   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

KANAMYCIN; NUCLEOTIDE; RIBOSOMAL PROTEIN S12; RIBOSOME PROTEIN; STREPTOMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; GENETIC MARKER; RPSL PROTEIN, E COLI;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BACTERIUM MUTANT; CLINICAL ASSESSMENT TOOL; COLONY FORMING UNIT; CONTROLLED STUDY; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE LOCATION; GROWTH INHIBITION; GROWTH RATE; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LD 50; LIVER ABSCESS; MALE; MARKER GENE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; RPSL GENE; SERUM; STRAIN DIFFERENCE; AMINO ACID SUBSTITUTION; ANIMAL; DEFICIENCY; DRUG EFFECTS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; GROWTH, DEVELOPMENT AND AGING; KLEBSIELLA INFECTION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MORTALITY; PATHOGENICITY; PATHOLOGY; SEQUENCE HOMOLOGY; SURVIVAL;

AMINO ACID SUBSTITUTION; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENETIC MARKERS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIVER ABSCESS; MICE; MICROBIAL SENSITIVITY TESTS; RIBOSOMAL PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; STREPTOMYCIN; SURVIVAL ANALYSIS;

EID: 84907483646     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109258     Document Type: Article

References (47)

1. Schatz A, Bugle E, Waksman SA (1944) Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc Soc Exp Biol Med 55:66-69.
2. Garcia-Migura L, Sunde M, Karlsmose S, Veldman K, Schroeter A, et al. (2012) Establishing streptomycin epidemiological cut-off values for Salmonella and Escherichia coli. Microb Drug Resist 18:88-93.
3. Galimand M, Sabtcheva S, Courvalin P, Lambert T (2005) Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob Agents Chemother 49:2949-2953.
4. Doi Y, Arakawa Y (2007) 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88-94.
5. Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME (2009) Do we still need the aminoglycosides? Int J Antimicrob Agents 33:201-205.
6. Madsen L, Aarestrup FM, Olsen JE (2000) Characterisation of streptomycin resistance determinants in Danish isolates of Salmonella Typhimurium. Vet Microbiol 75:73-82.
7. Sunde M, Norström M (2005) The genetic background for streptomycin resistance in Escherichia coli influences the distribution of MICs. J Antimicrob Chemother 56:87-90.
8. Finken M, Kirschner P, Meier A, Wrede A, Böttger EC (1993) Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 9:1239-1246.
9. Hughes D, Andersson DI (2001) Target alterations mediating antibiotic resistance. In Antibiotic Development and Resistance, Hughes D. and Andersson D. I. (eds.), Taylor and Francis, London and New Tork, pp 23-36.
10. Chiou CS, Jones AL (1995) Molecular analysis of high-level streptomycin resistance in Erwinia amylovora. Phytopathology 85:324-328.
11. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, et al. (2000) Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407:340-348.
12. Siu LK, Yeh K-M, Lin J-C, Fung C-P, Chang F-Y (2012) Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 12:881-887.
13. Reyrat J-M, Pelicic V, Gicquel B, Rappuoli R (1998) Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infect Immun 66:4011-4017.
14. Skorupski K, Taylor RK (1996) Positive selection vectors for allelic exchange. Gene 169:47-52.
15. Tsai YK, Fung CP, Lin JC, Chen JH, Chang FY, et al. (2011) Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55:1485-1493.
16. Wu Q, Stewart V (1998) NasFED proteins mediate assimilatory nitrate and nitrite transport in Klebsiella oxytoca (pneumoniae) M5al. J Bacteriol 180:1311-1322.
17. Huang CJ, Wang ZC, Huang HY, Huang HD, Peng HL (2013) YjcC, a c-di-GMP phosphodiesterase protein, regulates the oxidative stress response and virulence of Klebsiella pneumoniae CG43. PLoS One 8:e66740.
18. Chiang MK, Lu MC, Liu LC, Lin CT, Lai YC (2011) Impact of Hfq on global gene expression and virulence in Klebsiella pneumoniae. PLoS One 6:e22248.
19. Cheng HY, Chen YS, Wu CY, Chang HY, Lai YC, et al. (2010) RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J Bacteriol 192:3144-3158.
20. Lai YC, Peng HL, Chang HY (2003) RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level. J Bacteriol 185:788-800.
21. Drecktrah D, Douglas JM, Samuels DS (2010) Use of rpsL as a counterselectable marker in Borrelia burgdorferi. Appl Environ Microbiol 76:985-987.
22. Kim IK, Jeong WK, Lim SH, Hwang IK, Kim YH (2011) The small ribosomal protein S12P gene rpsL as an efficient positive selection marker in allelic exchange mutation systems for Corynebacterium glutamicum. J Microbiol Methods 84:128-130.
23. Sung CK, Li H, Claverys JP, Morrison DA (2001) An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol 67:5190-5196.
24. Sander P, Springer B, Bottger EC (2001) Gene replacement in Mycobacterium tuberculosis and Mycobacterium bovis BCG using rpsL as a dominant negative selectable marker. Methods Mol Med 54:93-104.
25. Sander P, Meier A, Bottger EC (1995) rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol 16:991-1000.
26. Barnard AM, Simpson NJ, Lilley KS, Salmond GP (2010) Mutations in rpsL that confer streptomycin resistance show pleiotropic effects on virulence and the production of a carbapenem antibiotic in Erwinia carotovora. Microbiology 156:1030-1039.
27. Björkman J, Hughes D, Andersson DI (1998) Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci USA 95:3949-3953.
28. Chumpolkulwong N, Hori-Takemoto C, Hosaka T, Inaoka T, Kigawa T, et al. (2004) Effects of Escherichia coli ribosomal protein S12 mutations on cell-free protein synthesis. Eur J Biochem 271:1127-1134.
29. Siu LK, Fung CP, Chang FY, Lee N, Yeh KM, et al. (2011) Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. J Clin Microbiol 49:3761-3765.
30. Yeh KM, Kurup A, Siu LK, Koh YL, Fung CP, et al. (2007) Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 45:466-471.
31. Gebreyes WA, Altier C (2002) Molecular characterization of multidrug-resistant Salmonella enterica subsp. enterica Serovar Typhimurium isolates from swine. J Clin Microbiol 40:2813-2822.
32. Yeh KM, Lin JC, Yin FY, Fung CP, Hung HC, et al. (2010) Revisiting the importance of virulence determinant magA and its surrounding genes in Klebsiella pneumoniae causing pyogenic liver abscesses: exact role in serotype K1 capsule formation. J Infect Dis 201:1259-1267.
33. Ohtomo R, Saito M (2003) A new selective medium for detection of Klebsiella from dairy environments. Microbes Environ 18:138-144.
34. Sander P, Springer B, Prammananan T, Sturmfels A, Kappler M, et al. (2002) Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother 46:1204-1211.
35. Nielsen KL, Pedersen TM, Udekwu KI, Petersen A, Skov RL, et al. (2012) Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J Antimicrob Chemother 67:1325-1332.
36. Heinzelmann M, Gardner SA, Mercer-Jones M, Roll AJ, Polk HC Jr (1999) Quantification of phagocytosis in human neutrophils by flow cytometry. Microbiol Immunol 43:505-512.
37. Campbell PA, Canono BP, Dervets DA, editors (1996) Isolation and functional analysis of neutrophils. New York: Wiley.
38. Lin JC, Chang FY, Fung CP, Xu JZ, Cheng HP, et al. (2004) High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes Infect 6:1191-1198.
39. Podschm R, Sievers D, Foscher A, Ullmann U (1993) Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis 168:1415-1421.
40. Fine DP (1977) Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infect Immun 16:124-128.
41. Fine DP, Marney SR Jr, Colley DG, Sergent JS, Des Prez RM (1972) C3 shunt activation in human serum chelated with EGTA. J Immunol 109:807-809.
42. Bugla-Ploskonska G, Korzeniowska-Kowal A, Guz-Regner K (2011) Reptiles as a source of Salmonella O48-clinically important bacteria for children: the relationship between resistance to normal cord serum and outer membrane protein patterns. Microb Ecol 61:41-51.
43. Eidinger D, Bello E, Mates A (1977) The heterocytotoxicity of human serum: I. Activation of the alternative complement pathway by heterologous target cells. Cell Immunol 29:174-186.
44. Sunde M (2005) Prevalence and characterization of class 1 and class 2 integrons in Escherichia coli isolated from meat and meat products of Norwegian origin. J Antimicrob Chemother 56:1019-1024.
45. Nhu NT, Lan NT, Phuong NT, Chau N, Farrar J, et al. (2012) Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. Int J Tuberc Lung Dis 16:527-531.
46. Betts MJ, Russell RB (2003) Amino acid properties and consequences of substitutions. Bioinformatics for Geneticists: John Wiley & Sons, Ltd. pp. 289-316.
47. Enne VI, Delsol AA, Davis GR, Hayward SL, Roe JM, et al. (2005) Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element. J Antimicrob Chemother 56:544-551.